Literature DB >> 22740516

Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.

Takuya Ito1, Tomohiro Murakawa, Hajime Sato, Aska Tanabe, Masaki Maekawa, Yukihiro Yoshida, Masashi Fukayama, Jun Nakajima.   

Abstract

OBJECTIVES: Pathological vessel invasion is a well-known prognostic factor in early-stage, non-small cell lung cancer and preoperative predicting vessel invasion may enable us to improve prognosis by additional interventions. We evaluated the importance of vessel invasion as a prognostic factor in clinical stage IA non-small cell lung cancer and predictive performance of simple diameter-based computed tomography image analysis for vessel invasion.
METHODS: The study design was retrospective, and we reviewed 398 patients who underwent surgical resection of clinical stage IA non-small cell lung cancer from 1999 to 2009. The prognostic factors for recurrence-free survival were examined by univariate and multivariate analyses. Additionally, we analyzed preoperative high-resolution computed tomography images of patients with adenocarcinoma. The greatest diameter of the tumor in the lung window and the length of the consolidation part of L in the mediastinal window were measured. Then the ratio (mediastinal window/lung window) was calculated, and the correlation between the ratio (mediastinal window/lung window) and vessel invasion was analyzed by receiver operating characteristic analysis.
RESULTS: Sixty-eight recurrences occurred. Multivariate analysis revealed that vessel invasion, high preoperative serum carcinoembryonic antigen, and history of other malignancy were independent prognostic factors; their hazard ratios were 2.98, 2.45, and 1.98, respectively. The receiver operating characteristic analysis showed that the area under the curve was 0.75. When we set the cut-off value of the ratio (mediastinal window/lung window) at 0.67, the sensitivity and specificity were 75% and 72%, respectively.
CONCLUSIONS: Vessel invasion had the greatest impact on recurrence in clinical stage IA non-small cell lung cancer. Our simple computed tomography image analysis showed good predictive performance for vessel invasion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740516      PMCID: PMC3445341          DOI: 10.1093/icvts/ivs163

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  14 in total

1.  Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis.

Authors:  Ukihide Tateishi; Hajime Uno; Kan Yonemori; Mistuo Satake; Masahiro Takeuchi; Yasuaki Arai
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

2.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society.

Authors:  J H Austin; N L Müller; P J Friedman; D M Hansell; D P Naidich; M Remy-Jardin; W R Webb; E A Zerhouni
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

3.  Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival.

Authors:  T Aoki; Y Tomoda; H Watanabe; H Nakata; T Kasai; H Hashimoto; M Kodate; T Osaki; K Yasumoto
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

4.  Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.

Authors:  Fumihiro Shoji; Akira Haro; Tsukihisa Yoshida; Kensaku Ito; Yosuke Morodomi; Tokujiro Yano; Yoshihiko Maehara
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

5.  Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas.

Authors:  Tetsuro Kondo; Kouzo Yamada; Kazumasa Noda; Haruhiko Nakayama; Yoichi Kameda
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

6.  Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings.

Authors:  Kazuya Takamochi; Junji Yoshida; Mitsuyo Nishimura; Tomoyuki Yokose; Satoshi Sasaki; Yutaka Nishiwaki; Kazuya Suzuki; Kanji Nagai
Journal:  Eur J Cardiothorac Surg       Date:  2004-05       Impact factor: 4.191

7.  Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.

Authors:  Haruhisa Matsuguma; Rie Nakahara; Masaki Anraku; Tetsuro Kondo; Yukio Tsuura; Yukari Kamiyama; Kiyoshi Mori; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2004-06       Impact factor: 4.191

8.  "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan.

Authors:  Kenji Suzuki; Hisao Asamura; Masahiko Kusumoto; Haruhiko Kondo; Ryosuke Tsuchiya
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

9.  The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma.

Authors:  Yasuhisa Ohde; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Kenro Takahashi; Kenji Suzuki; Kazuya Takamochi; Tomoyuki Yokose; Yutaka Nishiwaki
Journal:  Lung Cancer       Date:  2003-12       Impact factor: 5.705

10.  Lung adenocarcinoma can be subtyped according to tumor dimension by computed tomography mediastinal-window setting. Additional size criteria for clinical T1 adenocarcinoma.

Authors:  Yukinori Sakao; Takahiko Nakazono; Shinji Tomimitsu; Yuji Takeda; Toru Sakuragi; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Eur J Cardiothorac Surg       Date:  2004-12       Impact factor: 4.191

View more
  3 in total

Review 1.  Prediction of pleural invasion using different imaging tools in non-small cell lung cancer.

Authors:  Jhih-Hao Bai; Min-Shu Hsieh; Hsien-Chi Liao; Mong-Wei Lin; Jin-Shing Chen
Journal:  Ann Transl Med       Date:  2019-01

2.  A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.

Authors:  Tomoshi Tsuchiya; Ryotaro Kamohara; Masashi Muraoka; Takeshi Nagayasu; Sho Saeki; Mitsuhiro Takenoyama; Makoto Suzuki; Kazuo Inada; Shoji Tokunaga; Tomayoshi Hayashi; Shogo Urabe; Takaomi Koga; Shinji Akamine; Kenji Sugio
Journal:  BMC Cancer       Date:  2020-12-04       Impact factor: 4.430

3.  Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer.

Authors:  Hirofumi Morimoto; Yasuhiro Hida; Nako Maishi; Hiroshi Nishihara; Yutaka Hatanaka; Cong Li; Yoshihiro Matsuno; Toru Nakamura; Satoshi Hirano; Kyoko Hida
Journal:  Thorac Cancer       Date:  2021-03-11       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.